Death attributed to amobarbital and levomepromazine intoxication

Legal Medicine

Volumn 1, Issue 1, 1999, Pages 48-51

  Hino, Yukiko ^a   Ikeda, Noriaki ^a   Kudo, Keiko ^a   Tsuji, Akiko ^a   Sannohe, Seiya ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Amobarbital; GC MS; Levomepromazine; Poisoning

Indexed keywords

EID: 0038768084     PISSN: 13446223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1344-6223(99)80011-X     Document Type: Article

References (10)

1. Jitsufuchi N, Nagata T, Kudo K, Imamura T, Tokunaga H. Death due to asphyxia linked to antipsychotic drugs. Jpn J Legal Med 1995; 49: 255-9.
2. Lannas PA, Pachar JV. A fatal case of neuroleptic malignant syndrome. Med Sci Law 1993; 33: 86-8.
3. Lande G, Drouin E, Gauthier C, Chevallier JC, Godin JF, Chiffoleau A, et al. Arrhythmogenic effects of sultopride chlorhydrate: clinical and cellular electrophysiological correlation. Ann Fr Anesth 1992; 11: 629-35.
4. Lee MK, Ong SB, Tan CT, Loh TG. Neuroleptic malignant syndrome in Malaysia: a university hospital experience. Med J Malaysia 1992; 47: 200-7.
5. Winek CL. Drug & Chemical Blood-Level Data. Fisher Scientific; 1994.
6. Balasubramaniam K, Lucas SB, Mawer GE, Simons PJ. The kinetics of amylobarbitone metabolism in healthy men and women. Brit J Pharmacol 1970; 39: 564-72.
7. Dahl SG. Pharmacokinetics of methotrimeprazine after single and multiple doses. Clin Pharmacol Ther 1976; 19: 435-42.
8. Morris RW. Effects of phenothiazines on pentobarbital-induced sleep in mice. Arch Int Pharmacodyn Ther 1966; 161: 380-91.
9. Marzi E, Gambazza K, Piccinelli G, Garattini S, Bartosek I. Effect of optical isomers of (±)-fenfluramine on pentobarbitone brain and plasma concentrations and sleeping time. J Pharm Pharmacol 1981; 33: 677-9.
10. Hatanaka T, Negishi S, Katayama K, Kakemi M, Koizumi T. The pharmacodynamic and pharmacokinetic interaction of pentobarbital and chlorpromazine in rats. J Pharmacobio-Dyn 1988; 11: 47-52.